Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients
Conclusion: The present findings confirm that NLR based on peripheral blood counts prior to treatment can
be used as a prognostic factor in patients with glioblastoma. Since tumour aggression increases and survival decreases
as the NLR value rises, choice of treatment modality is facilitated for glioblastoma patients.
PMID: 29286221 [PubMed - as supplied by publisher]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Neurology | Study